Yu SY - Search Results

1

[Trastuzumab in combination with chemotherapy versus chemotherapy alone for first-line treatment of HER2-positive advanced gastric or gastroesophageal junction cancer: a Phase III, multi-center, randomized controlled trial, Chinese subreport].

Shen L, Xu JM, Feng FY, Jiao SC, Wang LW, Li J, Guan ZZ, Qin SK, Wang JJ, Yu SY, Wang YJ, Jin YN, Tao M, Zheng LZ, Pan LX. Shen L, et al. Among authors: yu sy. Zhonghua Zhong Liu Za Zhi. 2013 Apr;35(4):295-300. doi: 10.3760/cma.j.issn.0253-3766.2013.04.012. Zhonghua Zhong Liu Za Zhi. 2013. PMID: 23985260 Clinical Trial. Chinese.

2

[Result of phase II clinical trial of herceptin in advanced Chinese breast cancer patients].

Sun Y, Li LQ, Song ST, Xu LG, Yu SY, Wang JW, Jiang ZF, Yin JL, Xiong HH. Sun Y, et al. Among authors: yu sy. Zhonghua Zhong Liu Za Zhi. 2003 Nov;25(6):581-3. Zhonghua Zhong Liu Za Zhi. 2003. PMID: 14690567 Clinical Trial. Chinese.

3

[Transdermal fentanyl for the management of cancer pain: a survey of 1,664 elderly patients].

Yu SY, Sun Y, Zhang HC, Wu YL, Qin SK, Xie GR, Liu SJ, Sui G. Yu SY, et al. Zhonghua Yi Xue Za Zhi. 2003 Nov 25;83(22):1931-5. Zhonghua Yi Xue Za Zhi. 2003. PMID: 14703423 Chinese.

4

[First-line Xeloda (Capecitabine) treatment for advanced and recurrent colorectal cancer].

Guan ZZ, Liu DG, Yu BM, Wu WQ, Shi D, Zhao Y, Wei YQ, Zou LQ, Wu XD, Zhuang W, Feng FY, Zhang P, Yu SY, Xiong HH, Fu Q, Zheng S, Huang JJ, Wu G, Yang CY, Sun SR, Ruan QL. Guan ZZ, et al. Among authors: yu bm, yu sy. Zhonghua Zhong Liu Za Zhi. 2004 Feb;26(2):119-21. Zhonghua Zhong Liu Za Zhi. 2004. PMID: 15059335 Chinese.

5

[Transdermal fentanyl for the management of cancer pain: a survey of 4492 patients].

Yu SY, Sun Y, Wu YL, Qin SK, Xie GR, Liu SJ, Sui GJ, Zhang HC. Yu SY, et al. Zhonghua Zhong Liu Za Zhi. 2005 Jun;27(6):369-72. Zhonghua Zhong Liu Za Zhi. 2005. PMID: 16117902 Chinese.

6

[Comparison between R-CHOP regimen and CHOP regimen in treating naive diffuse large B-cell lymphoma in China--a multi-center randomized trail].

Lin TY, Zhang HY, Huang Y, Guan ZZ, Shen T, Shi YK, Zhu J, Ke XY, Wang HQ, Shen ZX, Yu SY, Liu T, Shi XL. Lin TY, et al. Among authors: yu sy. Ai Zheng. 2005 Dec;24(12):1421-6. Ai Zheng. 2005. PMID: 16351785 Clinical Trial. Chinese.

7

[Gefitinib in the treatment of advanced non-small-cell lung cancer].

Zhang L, Yu SY. Zhang L, et al. Among authors: yu sy. Zhonghua Zhong Liu Za Zhi. 2006 Jul;28(7):539-41. Zhonghua Zhong Liu Za Zhi. 2006. PMID: 17147123 Clinical Trial. Chinese.

8

[Consensus of experts on the management of malignant bowel obstruction in patients with advanced cancer].

Yu SY, Wang JJ, Wang JW. Yu SY, et al. Zhonghua Zhong Liu Za Zhi. 2007 Aug;29(8):637-40. Zhonghua Zhong Liu Za Zhi. 2007. PMID: 18210891 Chinese. No abstract available.

9

Gemcitabine and cisplatin treatment over a 3-week versus a 4-week dosing schedule: a randomized trial conducted in Chinese patients with nonsmall cell lung cancer.

Liao ML, Zhu YZ, Li LY, Wan HY, Yu SY, Hall B, West T, Wang L. Liao ML, et al. Among authors: yu sy. Chin Med J (Engl). 2008 May 20;121(10):892-7. Chin Med J (Engl). 2008. PMID: 18706202 Clinical Trial.

10

Fulvestrant 250 mg versus anastrozole for Chinese patients with advanced breast cancer: results of a multicentre, double-blind, randomised phase III trial.

Xu B, Jiang Z, Shao Z, Wang J, Feng J, Song S, Chen Z, Gu K, Yu S, Zhang Y, Wang C, Zhang F, Yang J. Xu B, et al. Cancer Chemother Pharmacol. 2011 Jan;67(1):223-30. doi: 10.1007/s00280-010-1483-x. Epub 2010 Oct 12. Cancer Chemother Pharmacol. 2011. PMID: 20938664 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,234 results

Search Page

Filters